Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00383760
What this trial is testing

Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

Who this might be right for
Adenocarcinoma of the PancreasPancreatic CancerRecurrent Pancreatic Cancer+3 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)WithdrawnNCT03127124
What this trial is testing

QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
NantPharma, LLC
Testing effectiveness (Phase 2)Study completedNCT01124786
What this trial is testing

A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Clovis Oncology, Inc. 367
Testing effectiveness (Phase 2)Study completedNCT00062283
What this trial is testing

Alanosine in Treating Patients With Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaPancreatic Cancer+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Very early researchStudy completedNCT01715142
What this trial is testing

Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma ResectablePancreatic Adenocarcinoma Locally AdvancedPancreatic Adenocarcinoma Metastatic
Jean-Luc Van Laethem 23
Early research (Phase 1)Looking for participantsNCT06451497
What this trial is testing

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Non Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaPancreas Adenocarcinoma+8 more
Zumutor Biologics Inc. 100
Not applicableLooking for participantsNCT07723261
What this trial is testing

Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Hellenic Cooperative Oncology Group 70
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Testing effectiveness (Phase 2)Study completedNCT06225999
What this trial is testing

Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Institut de Recherches Internationales Servier 41
Early research (Phase 1)Study completedNCT01783171
What this trial is testing

Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer AJCC v6 and v7+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT04983407
What this trial is testing

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Aravive, Inc. 34
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Testing effectiveness (Phase 2)Study completedNCT00474812
What this trial is testing

Dasatinib in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
National Cancer Institute (NCI) 51
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT04703920
What this trial is testing

Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer

Who this might be right for
Metastatic Breast CancerMetastatic Castration-resistant Prostate CancerMetastatic Ovarian Carcinoma+1 more
University of Michigan Rogel Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01417000
What this trial is testing

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Aduro Biotech, Inc. 93
Early research (Phase 1)Study completedNCT02045602
What this trial is testing

Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsPancreatic Adenocarcinoma
Theriva Biologics SL 42
Next Page